Medtronic, a global leader in healthcare technology, announced a strategic partnership with Cornerstone Robotics, an innovative surgical robotics company committed to advancing minimally invasive surgery and improving access to the latest surgical care worldwide. The approximately $700 million investment includes righ…
Monash Health, the largest public health service in Victoria, Australia, has signed a Memorandum of Understanding (MoU) with Data4Life, an international nonprofit digital health organization funded by the Hasso Plattner Foundation. The announcement was made by Associate Professor Tam C. Nguyen, Director of Research &a…
Harvest Integrated Research Organization (HiRO), a full-service global clinical research organization (CRO), and Differentia Biotech Ltd. ("Differentia"), a pioneer in knowledge-empowered modeling and simulation for drug development, announced a Memorandum of Understanding (MOU) establishing a strategic collaboration …
Samsung Biologics announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in the company's three-dimensional, long-term growth strategy across capacity, portfolio, and geographic expansion. The company plans to allocate approximately KRW 2.71 trillion of the offering …
The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU) have signed a Memorandum of Understanding (MoU) to establish a strategic partnership focused on advancing research and development in AI-enabled biomaterials and digital health technologies. The collaboration aim…
Rznomics Inc, a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Lilly Gateway Labs is a best-in-class innovation hub designed to empower biotechnology companies to advance groundbreaking science by…
Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navtemadlin in Phase III clinical development in myelofibrosis.
Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernise Novo Nordisk’s operations through agentic AI and cloud technologies. As part of the partnership, Novo Nordisk and AWS have created a co-innovation hub in London where engineers and scientists from bo…
Labcorp, a global leader of innovative and comprehensive laboratory services, and the National Association of Community Health Centers (NACHC) announced a strategic alliance to strengthen leadership development, support practice improvement and advance community health initiatives across the nation's Community Health …
Piramal Pharma Ltd. has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited, a Hyderabad-based CDMO specializing in vaccines and biologics for an aggregate cash consideration of ₹76 crore INR, or $7.95M USD. As a result of this transaction, PPL now owns 74% of Yapan Bio's equity, maki…
Page 1 of 39